Newsmeme!
Discover News you didn't know existed
In a study published June 22 online in Genome Research , researchers describe a new peptide classification and protein inference method that helped them identify around 3,500 proteins in pollen — around 13 times the previously reported pollen proteome.
It is based on detecting short, repetitive DNA segments in the genome of bacteria. Every single bacterial strain has such characteristic repeats. "With this method we are able to identify bacterial strains as well as clarify their genetic relationships. Furthermore, we can show how new pathogenic variants develop," says Manfred Höfle, researcher at the HZI.
Caliper Life Sciences Stays on Hold
Every year, diarrhea causes around five million fatalities worldwide. Most people die due to pathogenic microorganisms, such as bacteria or viruses, which were ingested into the gastro-intestinal tract through contaminated drinking water or food. Determining which bacterium is causing the illness in those cases is sometimes very complex. In cooperation with Chilean researchers, scientists from ...
( Helmholtz Association of German Research Centres ) Every year, diarrhea causes around five million fatalities worldwide. Most people die due to pathogenic micro-organisms, such as bacteria or viruses, which were ingested into the gastro-intestinal tract through contaminated drinking water or food. Determining which bacterium is causing the illness in those cases is sometimes very complex. In ...
LONDON, June 30 /PRNewswire/ -- Two-dimensional electrophoresis (2DE) is the most cost-effective protein profiling technology and is the only technology in which the constituents of a protein sample can be entirely visualised in a single gel.
Researchers from Helmholtz Centre for Infection Research, Germany, develop new method for better diagnostic of diarrhea causing bacteria.
- Caliper Addresses Key Bottlenecks in Quality by Design Initiative for Protein Therapeutics - HOPKINTON, Mass., June 29 Caliper Life Sciences, Inc.
Caliper Addresses Key Bottlenecks in Quality by Design Initiative for Protein Therapeutics -
Boston Heart Lab, a pioneer in specialized diagnostics for patients with heart disease, was named "Most Promising Early Stage Company" by Silicom Ventures at the angel investment organization's 2009 Investment Summit, which took place June 2-3, 2009, at Stanford University in California.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |